We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$1.43B
AUM Growth
+$297M
Cap. Flow
+$228M
Cap. Flow %
16%
Top 10 Hldgs %
15.34%
Holding
1,414
New
222
Increased
745
Reduced
184
Closed
249

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$11.4M
2
AAPL icon
Apple
AAPL
+$9.16M
3
MSFT icon
Microsoft
MSFT
+$6.62M
4
META icon
Meta Platforms (Facebook)
META
+$5.96M
5
AMZN icon
Amazon
AMZN
+$5.23M

Sector Composition

Rank Sector Weight
1 Technology 18.28%
2 Financials 14.25%
3 Healthcare 11.99%
4 Industrials 10.61%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYGN icon
976
Myriad Genetics
MYGN
$530M
$70K ﹤0.01%
+2,050
New +$69.2K
CCOI icon
977
Cogent Communications
CCOI
$594M
$69K ﹤0.01%
+1,525
New +$72.6K
LGND icon
978
Ligand Pharmaceuticals
LGND
$6.02B
$68K ﹤0.01%
+802
New +$69.5K
CSOD
979
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$68K ﹤0.01%
+1,925
New +$71.8K
IMMU
980
DELISTED
Immunomedics Inc
IMMU
$67K ﹤0.01%
+4,132
New +$48.8K
LOXO
981
DELISTED
Loxo Oncology, Inc
LOXO
$67K ﹤0.01%
+800
New +$66.7K
NWS icon
982
News Corp Class B
NWS
$16.4B
$65K ﹤0.01%
+3,939
New +$60.1K
AGIO icon
983
Agios Pharmaceuticals
AGIO
$2.16B
$61K ﹤0.01%
+1,075
New +$67.6K
EGHT icon
984
8x8 Inc
EGHT
$247M
$59K ﹤0.01%
+4,175
New +$57.7K
OPK icon
985
Opko Health
OPK
$921M
$59K ﹤0.01%
12,107
-52,594
-81% -$305K
TLRD
986
DELISTED
Tailored Brands, Inc.
TLRD
$57K ﹤0.01%
2,606
-3,177
-55% -$53.4K
EDIT icon
987
Editas Medicine
EDIT
$399M
$56K ﹤0.01%
+1,825
New +$46K
STMP
988
DELISTED
Stamps.com, Inc.
STMP
$56K ﹤0.01%
+297
New +$57.4K
CCO icon
989
Clear Channel Outdoor Holdings
CCO
$1.23B
$55K ﹤0.01%
11,985
DVAX
990
DELISTED
Dynavax Technologies
DVAX
$55K ﹤0.01%
+2,925
New +$58.7K
ICPT
991
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$55K ﹤0.01%
950
-1,136
-54% -$71.6K
ESND
992
DELISTED
Essendant Inc.
ESND
$55K ﹤0.01%
5,983
-42
-0.7% -$432
TVRD
993
Tvardi Therapeutics
TVRD
$23.5M
$54K ﹤0.01%
+122
New +$55.6K
GBX icon
994
The Greenbrier Companies
GBX
$1.61B
$53K ﹤0.01%
+996
New +$50K
ARNA
995
DELISTED
Arena Pharmaceuticals Inc
ARNA
$53K ﹤0.01%
+1,550
New +$44.2K
LYG icon
996
Lloyds Banking Group
LYG
$87.4B
$52K ﹤0.01%
13,790
-8,962
-39% -$32.3K
RARE icon
997
Ultragenyx Pharmaceutical
RARE
$2.65B
$51K ﹤0.01%
+1,100
New +$53.9K
MDC
998
DELISTED
M.D.C. Holdings, Inc.
MDC
$51K ﹤0.01%
1,865
-1,052
-36% -$29K
AMAG
999
DELISTED
AMAG Pharmaceuticals
AMAG
$51K ﹤0.01%
3,849
+1,032
+37% +$15.6K
CBL
1000
DELISTED
CBL& Associates Properties, Inc.
CBL
$51K ﹤0.01%
9,059
+463
+5% +$3.1K

Similar funds

Pacer Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Pacer Advisors held 1,414 positions worth $1.43B, up 26% from $1.13B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pacer Advisors deployed $228M of net new capital in Q4 2017, opening 222 new positions and adding to 745 existing holdings. Its largest new stake was Equinor: 118,925 shares worth $2.55M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $3.14M trimmed.

  • Pacer Advisors's largest Q4 2017 buy was Equinor: 118,925 shares worth $2.55M.
  • Pacer Advisors added most to Alphabet (Google) Class A in Q4 2017, an estimated $11.4M increase.
  • Pacer Advisors's biggest Q4 2017 reduction was Alphabet (Google) Class C, cutting an estimated $3.14M.
  • Pacer Advisors fully exited Adient in Q4 2017, selling an estimated $1.67M.
  • Pacer Advisors's ten largest holdings make up 15% of its $1.43B portfolio in Q4 2017.
  • Pacer Advisors opened 222 new positions and closed 249 in Q4 2017.
  • Pacer Advisors's portfolio value rose 26% quarter-over-quarter to $1.43B.

Based on Pacer Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.